Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

AC Immune (ACIU) Return on Capital Employed (2017 - 2025)

AC Immune has reported Return on Capital Employed over the past 8 years, most recently at 97.53% for Q4 2025.

  • Quarterly Return on Capital Employed fell 6009.0% to 97.53% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 97.53% through Dec 2025, down 6009.0% year-over-year, with the annual reading at 78.98% for FY2025, 2904.0% down from the prior year.
  • Return on Capital Employed was 97.53% for Q4 2025 at AC Immune, down from 87.05% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 0.64% in Q1 2021 and troughed at 97.53% in Q4 2025.
  • The 5-year median for Return on Capital Employed is 38.73% (2022), against an average of 35.78%.
  • Year-over-year, Return on Capital Employed soared 3932bps in 2023 and then tumbled -6023bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.4% in 2021, then tumbled by -9824bps to 38.93% in 2022, then soared by 101bps to 0.39% in 2023, then plummeted by -9623bps to 37.45% in 2024, then tumbled by -160bps to 97.53% in 2025.
  • Per Business Quant, the three most recent readings for ACIU's Return on Capital Employed are 97.53% (Q4 2025), 87.05% (Q3 2025), and 51.3% (Q2 2025).